Abstract
Antifungal resistance is a growing threat to public health, with a drastic reduction in the effectiveness of classic antifungals, such as azoles. Thousands of people die annually as a consequence of fungal infections associated with the long-term use of broad-spectrum antibiotics, immunosuppressive therapies, ICU admissions, extensive burns, major surgery, malignancy and, currently, the C…